CR11248A - Compuestos anti-virales, composiciones y metodos de uso - Google Patents

Compuestos anti-virales, composiciones y metodos de uso

Info

Publication number
CR11248A
CR11248A CR11248A CR11248A CR11248A CR 11248 A CR11248 A CR 11248A CR 11248 A CR11248 A CR 11248A CR 11248 A CR11248 A CR 11248A CR 11248 A CR11248 A CR 11248A
Authority
CR
Costa Rica
Prior art keywords
compositions
methods
viral compounds
compounds
virus
Prior art date
Application number
CR11248A
Other languages
English (en)
Inventor
Martin Robert Leivers
Jesse Daniel Keicher
Franz Ulrich Schmitz
Roopa Rai
Ryan Lauchli
Sebastian Reinhard Johannes Liehr
Stephanie Anna Chan
Toney Loc Ton
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CR11248A publication Critical patent/CR11248A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se dan a conocer compuestos de la Formula (I): sales farmaceuticamente aceptables, y solvatos de los mismos, composiciones de los mismos, y metodos para su preparacion y uso para el tratamiento de infecciones virales mediadas cuando menos en parte por un virus de la familia de virus Flaviviridae.
CR11248A 2007-07-13 2010-02-02 Compuestos anti-virales, composiciones y metodos de uso CR11248A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94975807P 2007-07-13 2007-07-13

Publications (1)

Publication Number Publication Date
CR11248A true CR11248A (es) 2010-10-05

Family

ID=39929680

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11248A CR11248A (es) 2007-07-13 2010-02-02 Compuestos anti-virales, composiciones y metodos de uso

Country Status (13)

Country Link
US (2) US20110044943A1 (es)
EP (1) EP2178877A1 (es)
JP (1) JP2010533183A (es)
KR (1) KR20100056462A (es)
AU (1) AU2008276611A1 (es)
BR (1) BRPI0814300A2 (es)
CA (1) CA2693793A1 (es)
CR (1) CR11248A (es)
EA (1) EA201000051A1 (es)
MA (1) MA31598B1 (es)
TW (1) TW200920372A (es)
WO (1) WO2009011787A1 (es)
ZA (1) ZA201000992B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1838152A2 (en) * 2005-01-21 2007-10-03 Neurogen Corporation Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
JP2010519174A (ja) * 2006-09-18 2010-06-03 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔの複素環阻害薬およびその使用方法
UY31685A (es) * 2008-03-04 2009-11-10 Smithkline Beecham Corp Compuestos antivirales, composiciones y metodos para usarlos
KR101220182B1 (ko) 2009-02-25 2013-01-11 에스케이바이오팜 주식회사 치환된 아졸 유도체 화합물, 이를 포함하는 약제학적 조성물 및 이를 이용한 파킨슨씨 병 치료방법
US20110053892A1 (en) * 2009-08-31 2011-03-03 Martin Leivers Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections
EP2545964A1 (en) 2011-07-13 2013-01-16 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
CA2968836C (en) 2016-06-13 2025-09-02 Gilead Sciences, Inc. FXR MODULATING COMPOUNDS (NR1H4)
NZ748641A (en) 2016-06-13 2020-04-24 Gilead Sciences Inc Fxr (nr1h4) modulating compounds
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
SI4122464T1 (sl) 2017-03-28 2024-07-31 Gilead Sciences, Inc. Terapevtske kombinacije za zdravljenje bolezni jeter
PT3911647T (pt) 2019-01-15 2024-03-04 Gilead Sciences Inc Composto de isoxazole como agonista de fxr e composições farmacêuticas que o contenham
JP2022519906A (ja) 2019-02-19 2022-03-25 ギリアード サイエンシーズ， インコーポレイテッド Ｆｘｒアゴニストの固体形態
AU2020321955A1 (en) 2019-07-30 2022-03-17 Eikonizo Therapapeutics, Inc. HDAC6 inhibitors and uses thereof
TW202345813A (zh) 2022-04-08 2023-12-01 美商艾科尼佐療法股份有限公司 㗁二唑ｈｄａｃ６抑制劑及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161273B1 (en) * 2003-12-22 2015-04-15 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
BRPI0513811A (pt) * 2004-07-27 2008-07-15 Gilead Sciences Inc imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
AU2005286790A1 (en) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
NZ556624A (en) * 2004-12-21 2010-06-25 Gilead Sciences Inc 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine and method of antiviral treatment
FR2909090B1 (fr) * 2006-11-23 2009-01-09 Sanofi Aventis Sa Derives de 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one substitues,leur preparation et leur application en therapeutique.
US20110053892A1 (en) * 2009-08-31 2011-03-03 Martin Leivers Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections

Also Published As

Publication number Publication date
TW200920372A (en) 2009-05-16
JP2010533183A (ja) 2010-10-21
WO2009011787A1 (en) 2009-01-22
ZA201000992B (en) 2011-04-28
MA31598B1 (fr) 2010-08-02
US20090074717A1 (en) 2009-03-19
KR20100056462A (ko) 2010-05-27
CA2693793A1 (en) 2009-01-22
AU2008276611A1 (en) 2009-01-22
EP2178877A1 (en) 2010-04-28
BRPI0814300A2 (pt) 2015-02-03
EA201000051A1 (ru) 2010-08-30
US20110044943A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
CR11248A (es) Compuestos anti-virales, composiciones y metodos de uso
UY31685A (es) Compuestos antivirales, composiciones y metodos para usarlos
WO2011041713A3 (en) Piperazinyl antiviral agents
ECSP12011684A (es) Inhibidores de los virus flaviviridae.
NI200700102A (es) Derivados de indol tetraciclicos como agentes antiviricos
PY1153144A (es) Inhibidores macrocíclicos de virus flaviviridae
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
CL2009000305A1 (es) Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv).
EA200901241A1 (ru) Соединения для лечения гепатита с
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
CO6390076A2 (es) Inhibidores de hcv ns5a
CO6390077A2 (es) Inhibidores de hacv ns5a
CO6561783A2 (es) Inhibidores del virus flaviviridae
CL2012001176A1 (es) Compuestos derivados de bencimidazol-imidazol, inhibidores del virus de la hepatitis c (hcv); composición farmacéutica que los comprende; combinación farmacéutica; uso en la prevención o tratamiento de infección de hcv.
CO6592102A2 (es) Compuestos de sililo triciclicos fusionados y metodos de uso de los mismos para el tratamiento de enfermedades virales
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
BR112013007696A2 (pt) composto, composição farmacêutica, usos do referido composto e da referida composição
CL2011000136A1 (es) Compuestos derivados de 3-fenilpiridin-2-ona, inhibidores de rna polimerasa dependiente de rna viral; composicion faramceutica que comprende dichos compuestos; y su uso para el tratamiento de una enfermedad causada por el virus de la hepatitis c.
UY28581A1 (es) Compuestos nucleosidicos para el tratamiento de infecciones virales
WO2010062821A8 (en) Anti-viral compounds, compositions, and methods of use
CL2008002539A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
WO2008070447A3 (en) Anti-viral compounds
CL2008003431A1 (es) Compuestos derivados de nucleosidos 2',4' sustituidos; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su metodo de preparacion; y su uso para el tratamiento y/o la prevencion de cualquier condicion resultante de una infeccion por vhb, vhc o vih.
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
HRP20070435A2 (hr) Triciklički nukleozidni spojevi za liječenje virusnih infekcija

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)